Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Xvivo Perfusion
OM:XVIVO Community
1
Narratives
written by author
0
Comments
on narratives written by author
13
Fair Values set
on narratives written by author
Create a narrative
Xvivo Perfusion
Popular
Undervalued
Overvalued
Xvivo Perfusion
WA
Analyst Price Target
Consensus Narrative from 6 Analysts
Success Of US Heart Trial Will Strengthen Position In Heart Transplantation Market
Key Takeaways Strategic acquisitions and production scaling are anticipated to enhance sales growth, operational efficiency, and improve gross margin profitability. Success in heart trials and new program launches are expected to expand market share and enhance future revenue streams.
View narrative
SEK 518.67
FV
21.9% undervalued
intrinsic discount
39.16%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
XVIVO
Xvivo Perfusion
Your Fair Value
SEK
Current Price
SEK 405.00
64.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-44m
3b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 3.0b
Earnings SEK 629.2m
Advanced
Set as Fair Value